Back to results
US 2024/0192237 A1Published application
Methods for optimizing treatment of mental disorders with cannabidiol and pharmaceutical compositions comprising cannabidiol
AssigneeCurantis UG
InventorFranz-Markus LEWEKE
Life of this patent
Estimating the term…
Abstract
Methods for optimizing treatment of mental disorders with cannabidiol and pharmaceutical compositions including cannabidiol.
Claims15
An in vitro method for determining efficacy of a treatment of a subject having a mental disorder by administration of cannabidiol, the method comprising
- determining in vitro a level of cannabidiol in a sample from said subject having said mental disorder,
- wherein said treatment is considered efficient if the level of cannabidiol is at least 25 μg/l.
A pharmaceutical composition comprising at least 99% cannabidiol without any added excipients having a particle size of less than 0.8 mm.
A capsule comprising a pharmaceutical composition including at least 99% cannabidiol without any added excipients having a particle size of less than 0.8 mm.
Dependencies are inferred from the claim text.